Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.

Journal of neuro-oncology - 1 Sept 2000

Schiebe M, Ohneseit P, Hoffmann W, Meyermann R, Rodemann H P, Bamberg M

Abstract excerpt

Malignant gliomas are the most frequent primary brain tumors. Recent studies defined several genetic markers, which might characterize molecular-biological subsets of glioblastomas with probably prognostic implications. To elucidate the involvement of murine-double-minute (mdm)2 gene amplificatio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Gene Amplification
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Nuclear Proteins

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-mdm2

Share to Survival Analysis

Source

Identifiers

PMID: 11212898
DOI: 10.1023/a:1006410702284

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11212898-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.PMID 11212898Read ↗

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.Semantic proximity Read ↗

Amplification and Overexpression of MDM2 in Primary (de novo) GlioblastomasSemantic proximity Read ↗

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.Semantic proximity Read ↗

The Role of MDM2 Amplification and Overexpression in Tumorigenesis.Semantic proximity Read ↗

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.Semantic proximity Read ↗

Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 AlterationSemantic proximity Read ↗

p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours.Semantic proximity Read ↗

MDM2 inhibitors in sarcomas: results and next stepsSemantic proximity Read ↗

The MDM2 gene amplification databaseSemantic proximity Read ↗

The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem CellsSemantic proximity Read ↗

Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.Semantic proximity Read ↗

Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.